rentosertib
Phase 2- Indications
- Idiopathic pulmonary fibrosis
Company intelligence / Profile preview
InSilicoTrials offers a commercial cloud-based AI simulation platform that accelerates pharmaceutical and medical device R&D by predicting safety/efficacy outcomes. The company does not develop its own drugs but provides digital tools to reduce the need for animal studies and clinical trials. Its technology has been adopted by pharma/biotech companies globally to improve trial design efficiency and regulatory submissions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InSilicoTrials.